ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,985Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 939

$1.39M Total Retail Price of All Prescriptions

Rank: 14 out of 939

774 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 774 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 774 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 16,948 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 998 733 1 2
FUROSEMIDE 913 679 2 7
OMEPRAZOLE 795 501 3 5
HYDROCODONE-ACETAMINOPHEN 766 347 S3 4 1
LEVOTHYROXINE SODIUM 662 439 5 4
METFORMIN HCL 653 353 6 8
POTASSIUM CHLORIDE 633 455 7 9
GABAPENTIN 587 327 8 11
LISINOPRIL 563 339 9 3
TRAMADOL HCL 519 361 10 16
AMLODIPINE BESYLATE 504 383 11 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 460 332 12 23
NEXIUM 387 187 13 18
KLOR-CON M20 352 316 14 90
GLIMEPIRIDE 348 223 15 37
CEPHALEXIN 329 201 16 77
CITALOPRAM HBR 326 184 17 15
DIGOXIN 322 233 18 45
WARFARIN SODIUM 316 298 19 17
DONEPEZIL HCL 313 300 20 30
METOPROLOL TARTRATE 305 208 21 10
TRIAMTERENE-HCTZ 296 214 22 33
METOPROLOL SUCCINATE 281 224 23 21
CLOPIDOGREL 254 194 24 28
ISOSORBIDE MONONITRATE ER 237 207 25 53
CIPROFLOXACIN HCL 219 148 26 54
MELOXICAM 215 113 27 14
ALLOPURINOL 204 152 28 31
NAPROXEN 200 111 29 72
PRAVASTATIN SODIUM 199 169 30 13
ZOLPIDEM TARTRATE 196 93 31 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 195 104 32 64
ROPINIROLE HCL 194 104 33 78
GLIPIZIDE 193 151 34 52
SERTRALINE HCL 184 149 35 24
ATENOLOL 170 103 36 19
PLAVIX 169 131 37 48
CYCLOBENZAPRINE HCL 161 56 R 38 36
PROMETHAZINE HCL 155 60 R 39 68
RISPERIDONE 154 97 40 82
SPIRIVA 153 107 41 73
AMITRIPTYLINE HCL 152 65 R 42 38
ACETAMINOPHEN-CODEINE 149 83 S3 43 116
SUCRALFATE 147 101 44 96
PAROXETINE HCL 147 93 44 70
FAMOTIDINE 145 98 46 62
CRESTOR 143 88 47 34
VERAPAMIL ER 137 105 48 85
PANTOPRAZOLE SODIUM 135 120 49 66
CARVEDILOL 133 92 50 25
METHYLPREDNISOLONE 128 73 51 118
LOSARTAN-HYDROCHLOROTHIAZIDE 127 80 52 55
VENTOLIN HFA 127 75 52 80
PREDNISONE 126 90 54 42
TRAZODONE HCL 125 75 55 26
MIRTAZAPINE 121 90 56 56
ADVAIR DISKUS 121 88 56 60
LYRICA 118 47 58 63
HYDROCHLOROTHIAZIDE 117 95 59 12
NAMENDA 115 103 60 49
DIOVAN 109 109 61 50
TRIAMCINOLONE ACETONIDE 106 71 62 150
TAMSULOSIN HCL 105 86 63 27
PROAIR HFA 100 69 64 41
TRIAMTERENE-HYDROCHLOROTHIAZID 97 55 65 115
EXELON 97 85 65 151
FLUOXETINE HCL 96 51 67 47
PREMARIN 95 29 R 68 111
ATORVASTATIN CALCIUM 94 77 69 22
ALENDRONATE SODIUM 94 70 69 40
DETROL LA 93 79 71 155
DOXYCYCLINE HYCLATE 92 52 72 84
CYMBALTA 90 42 73 44
POLYETHYLENE GLYCOL 3350 89 74 74 57
LOSARTAN POTASSIUM 86 67 75 29
AZITHROMYCIN 86 52 75 32
CLONIDINE HCL 85 64 77 39
AMLODIPINE BESYLATE-BENAZEPRIL 81 51 78 58
SINGULAIR 81 58 78 101
FLUTICASONE PROPIONATE 80 54 80 43
INSULIN SYRINGE 75 44 81 97
CARBIDOPA-LEVODOPA 72 38 82 102
BUMETANIDE 71 56 83 124
FENTANYL 70 25 S2 84 104
MEGESTROL ACETATE 69 62 R 85 136
VESICARE 69 34 85 202
SYNTHROID 68 65 87 75
KLOR-CON 10 68 51 87 158
SPIRONOLACTONE 68 29 87 71
ENALAPRIL MALEATE 66 62 90 65
ABILIFY 66 33 90 156
LANTUS 64 59 92 59
FLUCONAZOLE 64 15 92 140
GLYBURIDE-METFORMIN HCL 64 56 R 92 98
HYDRALAZINE HCL 64 49 92 130
AMOX TR-POTASSIUM CLAVULANATE 63 31 96 144
LABETALOL HCL 62 39 97 198
CARISOPRODOL 62 0 R 97 51
METOCLOPRAMIDE HCL 61 20 99 119
ESTRADIOL 59 32 R 100 79
COMBIVENT 59 38 100 120
MECLIZINE HCL 57 34 102 134
IBUPROFEN 55 31 103 112
NIASPAN 54 26 104 183
KLOR-CON M10 53 51 105 163
JANUVIA 53 33 105 110
QUETIAPINE FUMARATE 53 26 105 69
DOXAZOSIN MESYLATE 53 29 105 108
AGGRENOX 52 52 109 153
NIFEDIPINE ER 51 38 110 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.